![]() |
Nintedanib in combination with paclitaxel achieves total remission of tumors in 50 pe
The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50% of patients suffering from early HER-2- negative breast cancer, the...
More... |
| All times are GMT -7. The time now is 03:35 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021